VolitionRX Ltd (AMEX: VNRX) kicked off on Tuesday, up 10.79% from the previous trading day, before settling in for the closing price of $0.32. Over the past 52 weeks, VNRX has traded in a range of $0.31-$0.94.
During the last 5-year period, the sales growth of Healthcare Sector giant was 5.38%. While this was happening, its average annual earnings per share was recorded 31.18%. With a float of $96.64 million, this company’s outstanding shares have now reached $109.62 million.
VolitionRX Ltd (VNRX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of VolitionRX Ltd is 21.30%, while institutional ownership is 21.27%. The most recent insider transaction that took place on Nov 17 ’25, was worth 7,000. In this transaction President and CEO of this company bought 20,000 shares at a rate of $0.35, taking the stock ownership to the 2,554,847 shares. Before that another transaction happened on Oct 14 ’25, when Company’s President and CEO bought 110,000 for $0.51, making the entire transaction worth $56,100. This insider now owns 2,534,847 shares in total.
VolitionRX Ltd (VNRX) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.06 earnings per share (EPS), lower than consensus estimate (set at -0.05) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 31.18% per share during the next fiscal year.
VolitionRX Ltd (AMEX: VNRX) Trading Performance Indicators
Take a look at VolitionRX Ltd’s (VNRX) current performance indicators. Last quarter, stock had a quick ratio of 0.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 29.24.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.23, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.11 in one year’s time.
Technical Analysis of VolitionRX Ltd (VNRX)
Looking closely at VolitionRX Ltd (AMEX: VNRX), its last 5-days average volume was 0.97 million, which is a jump from its year-to-date volume of 0.32 million. As of the previous 9 days, the stock’s Stochastic %D was 11.14%.
During the past 100 days, VolitionRX Ltd’s (VNRX) raw stochastic average was set at 7.28%, which indicates a significant decrease from 24.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0397 in the past 14 days, which was lower than the 0.0472 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5106, while its 200-day Moving Average is $0.5772. However, in the short run, VolitionRX Ltd’s stock first resistance to watch stands at $0.3689. Second resistance stands at $0.3879. The third major resistance level sits at $0.4168. If the price goes on to break the first support level at $0.3210, it is likely to go to the next support level at $0.2921. Now, if the price goes above the second support level, the third support stands at $0.2731.
VolitionRX Ltd (AMEX: VNRX) Key Stats
The company with the Market Capitalisation of 42.98 million has total of 122,802K Shares Outstanding. Its annual sales at the moment are 1,230 K in contrast with the sum of -26,970 K annual income. Company’s last quarter sales were recorded 630 K and last quarter income was -5,380 K.
